Lack of support for bexarotene as a treatment for Alzheimer's disease

Eugene O'Hare, Ross Jeggo, Eun-Mee Kim, Bridgeen Barbour, Jean-Sebastien Walczak, Philip Palmer, Taylor Lyons, Deaglan Page, Donncha Hanna, Jolyon R. Meara, David Spanswick, Jian-Ping Guo, Edith G. McGeer, Patrick L. McGeer, Peter Hobson

Research output: Contribution to journalArticle

16 Citations (Scopus)
LanguageEnglish
Pages124-130
JournalNEUROPHARMACOLOGY
Volume100
Early online date27 May 2015
DOIs
Publication statusPublished - 1 Jan 2016

Cite this

O'Hare, E., Jeggo, R., Kim, E-M., Barbour, B., Walczak, J-S., Palmer, P., ... Hobson, P. (2016). Lack of support for bexarotene as a treatment for Alzheimer's disease. 100, 124-130. https://doi.org/10.1016/j.neuropharm.2015.04.020
O'Hare, Eugene ; Jeggo, Ross ; Kim, Eun-Mee ; Barbour, Bridgeen ; Walczak, Jean-Sebastien ; Palmer, Philip ; Lyons, Taylor ; Page, Deaglan ; Hanna, Donncha ; Meara, Jolyon R. ; Spanswick, David ; Guo, Jian-Ping ; McGeer, Edith G. ; McGeer, Patrick L. ; Hobson, Peter. / Lack of support for bexarotene as a treatment for Alzheimer's disease. 2016 ; Vol. 100. pp. 124-130.
@article{39d582d4c3314e9bb36702556f1a7f48,
title = "Lack of support for bexarotene as a treatment for Alzheimer's disease",
author = "Eugene O'Hare and Ross Jeggo and Eun-Mee Kim and Bridgeen Barbour and Jean-Sebastien Walczak and Philip Palmer and Taylor Lyons and Deaglan Page and Donncha Hanna and Meara, {Jolyon R.} and David Spanswick and Jian-Ping Guo and McGeer, {Edith G.} and McGeer, {Patrick L.} and Peter Hobson",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.neuropharm.2015.04.020",
language = "English",
volume = "100",
pages = "124--130",

}

O'Hare, E, Jeggo, R, Kim, E-M, Barbour, B, Walczak, J-S, Palmer, P, Lyons, T, Page, D, Hanna, D, Meara, JR, Spanswick, D, Guo, J-P, McGeer, EG, McGeer, PL & Hobson, P 2016, 'Lack of support for bexarotene as a treatment for Alzheimer's disease', vol. 100, pp. 124-130. https://doi.org/10.1016/j.neuropharm.2015.04.020

Lack of support for bexarotene as a treatment for Alzheimer's disease. / O'Hare, Eugene; Jeggo, Ross; Kim, Eun-Mee; Barbour, Bridgeen; Walczak, Jean-Sebastien; Palmer, Philip; Lyons, Taylor; Page, Deaglan; Hanna, Donncha; Meara, Jolyon R.; Spanswick, David; Guo, Jian-Ping; McGeer, Edith G.; McGeer, Patrick L.; Hobson, Peter.

Vol. 100, 01.01.2016, p. 124-130.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lack of support for bexarotene as a treatment for Alzheimer's disease

AU - O'Hare, Eugene

AU - Jeggo, Ross

AU - Kim, Eun-Mee

AU - Barbour, Bridgeen

AU - Walczak, Jean-Sebastien

AU - Palmer, Philip

AU - Lyons, Taylor

AU - Page, Deaglan

AU - Hanna, Donncha

AU - Meara, Jolyon R.

AU - Spanswick, David

AU - Guo, Jian-Ping

AU - McGeer, Edith G.

AU - McGeer, Patrick L.

AU - Hobson, Peter

PY - 2016/1/1

Y1 - 2016/1/1

U2 - 10.1016/j.neuropharm.2015.04.020

DO - 10.1016/j.neuropharm.2015.04.020

M3 - Article

VL - 100

SP - 124

EP - 130

ER -

O'Hare E, Jeggo R, Kim E-M, Barbour B, Walczak J-S, Palmer P et al. Lack of support for bexarotene as a treatment for Alzheimer's disease. 2016 Jan 1;100:124-130. https://doi.org/10.1016/j.neuropharm.2015.04.020